socalTECH

SEPTEMBER 24, 2021

San Diego-based biotech Kintara says it is raising $15.0M in a common stock and warrant offering from unmaned "healthcare-focused institutional investors". The company--which is novel cancer therapies for patients who are failing, or are resistant to, current treatment regimens--currently trades on the Nasdaq as KTRA.

San Diego 113

San Diego .Net Study Acquisition 113

socalTECH

SEPTEMBER 21, 2020

San Diego-based life sciences equipment maker Illumina announced this morning that it has acquired Menlo Park-based GRAIL , a developer of cancer early detection technology. According to Illumina, it will acquire GRAIL for cash and stock worth $8 billion. GRAIL is developing a multi-cancer screening test. billion in cash and $4.5

Artificial Inteligence 124

Artificial Inteligence San Diego Screening Study 124

Xconomy

SEPTEMBER 15, 2016

That’s according to a report being released today by Connect, the local nonprofit group focused on technology and entrepreneurship. The Connect Innovation Report found that 405 software, technology, and life sciences startups were created last year in San Diego County.

San Diego 40

San Diego Report High Tech Study 40

socalTECH

MARCH 28, 2019

San Diego-based biotech startup Biolinq , which is developing wireless-enabled biosensor patches for continuous monitoring of biomarkers, has raised $4.75M additional Series A funding, the company said this morning. The company said the new funding will go towards its technology platform, and to fund additional clinical studies.

Marketing 168

Marketing San Diego Venture Capital Study 168

Xconomy

MARCH 28, 2019

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Founders Jared Tagney and Joshua Windmiller, who met while in grad school at UC San Diego, started the company in 2012 as Electrozyme.

San Diego 103

San Diego Study Research Design 103

socalTECH

APRIL 28, 2017

San Diego-based Epic Sciences has raised $40M in a Series D funding, for its cancer testing technology, the company announced Friday morning. The company said the fund will go to accelerate clinical studies and enhance its technology. Epic Sciences is led by President and CEO Murali Prahalad, Ph.D. READ MORE>>.

Funding 153

Funding San Diego Study Capital 153

socalTECH

AUGUST 5, 2010

Carslbad-based Life Technologies , a developer of genomic analysis technology, and the University of California at San Diego 's Moores Cancer Center, said this morning that the two are collaborating on a research effort. Tags: life technologies ucsd genomics biotech lifescience.

UCSD 145

UCSD Technology San Diego Study 145

socalTECH

APRIL 1, 2020

San Diego-based Aspen Neuroscience , a biotechnology company developing treatments for Parkinson disease, said it has raised $70M in a Series A funding round. The company said its technology is based on the work of stem cell scientist Dr. Jeanne Loring.

San Diego 113

San Diego Screening Study Course 113

SoCal Tech Calendar

FEBRUARY 15, 2017

Wednesday, February 15, 2017 -- CASE STUDY: FuelRod -- Mobile Charging on the Go. MIT Enterprise Forum San Diego. One company is rethinking the world of mobile power through rechargeable batteries; in a way you might not expect. See [link] (more)

Enterprise Forum 100

Enterprise Forum Mobile Case Study San Diego 100

socalTECH

SEPTEMBER 12, 2018

San Diego-based Epic Sciences , which is developing technology around personalization of cancer treatment and management, has raised $52M more in a Series E funding, the company's lead investor said this morning.

Artificial Inteligence 100

Artificial Inteligence San Diego Study Invest 100

socalTECH

DECEMBER 6, 2012

San Diego-based Avelas Biosciences has raised $7.65M in a Series A funding round, which it says will go towards clinical studies for its technology for real-time tumor visualization. Avelas is developing technology for visualizing cancerous lymph nodes in breast cancer patients. READ MORE>>.

Avalon 138

Avalon San Diego Study Technology 138

Xconomy

NOVEMBER 3, 2017

Plante is a technology industry veteran in San Diego who has served as the CEO of Bel-Tronics, and as the founding CEO of SmartDrive Systems and Pathway Genomics. Studies in mice have. Thynk Capital founder and principal Jim Plante also is Klotho’s founder and CEO.

San Diego 85

San Diego Study Capital Technology 85

socalTECH

JUNE 4, 2014

That''s the idea behind a new project being run by San Diego-based Gimbal , the Qualcomm spinoff, in an effort with the Department of Health and Human Services (HHS) IDEA Lab. The new "Project Boundary" uses proximity beacons from Qualcomm, and also uses Apple''s iBeacon technology. READ MORE>>.

Study 153

Study San Diego Ideas Research 153

socalTECH

FEBRUARY 9, 2011

The number of Southern California related initial public offerings is growing steadily upwards, as Gevo --originally started in Pasadena, and based on technology out of Caltech and UCLA--hit the market this morning. Gevo is just the latest in a surge of companies hitting the public markets which have Southern California links.

Southern California 200

Southern California Westlake Village Woodland Hills Beverly Hills 200

Xconomy

OCTOBER 23, 2018

“ Artificial intelligence will transform the education system.” “ Immersive technology will reshape learning forever.” The truth is: technology alone isn’t the answer. The truth is: technology alone isn’t the answer. With back-to-school season in full swing, it’s imperative that we set the record straight.

Education 86

Education Artificial Inteligence Technology San Diego 86

Xconomy

APRIL 9, 2020

Multiple COVID-19 vaccine candidates that use a new technology called messenger RNA are now being readied for clinical trials that Pfizer and BioNTech plan to start in coming weeks. The partnership pairs the mRNA vaccine technology of BioNTech (NASDAQ: BNTX ) with the vaccine and clinical trial experience of Pfizer (NYSE: PFE ).

Study 122

Study Sites Technology San Diego 122

Xconomy

OCTOBER 5, 2016

San Diego-based Organovo (NASDAQ: ONVO ) said today it plans to use its 3D bio-printing technology to produce living human liver tissue “patches” that can be transplanted in patients with fatal liver disease. liver transplant waiting list. The transplanted liver tissue even produced liver-specific proteins and metabolic enzymes.

San Diego 105

San Diego Outsource Development Study Sample 105

socalTECH

MAY 7, 2010

According to DOE Secretary Steven Chu, it has selected thirteen award winners in Concentrating Solar Power Systems Studies, and Concentrating Solar Power Component Feasibility Studies. for building a solar power tower plant design; San Diego-based General Atomics getting up to $2.1M Department of Energy.

Canoga Park 186

Canoga Park Research Southern California Chatsworth 186

Xconomy

NOVEMBER 2, 2018

The gene-editing technology CRISPR-Cas9 is opening up new research avenues all the time, such as giving drug developers a cheaper, faster way to knock out genes in tumor cells. Studies of CRISPR-Cas9 to treat human disease are about to start, too. This week, we reported on a new study that raises exactly that question.

Study 74

Study Startup Research Report 74

socalTECH

FEBRUARY 19, 2016

San Diego-based eFFECTOR Therapeutics , which is developing gene translation technology to help in the treatment of cancer, has boosted its Series B funding to $56M, the company said Friday. The company--which raised $40M in the round back in December--said the new funding came from Sectoral Asset Management. Maha Katabi, Ph.D.,

San Diego 100

San Diego Funding Capital Help 100

Xconomy

SEPTEMBER 2, 2016

Nobel Prize winner Roger Tsien, a UC San Diego chemist, passed away in Oregon this week. As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.

News 57

News San Diego Journal Technical Review 57

Xconomy

NOVEMBER 28, 2018

In his first public appearance since his stunning claim, released on YouTube Sunday , that he and associates have helped bring the first genome-edited humans into the world, He Jiankui, a genomics researcher at Southern University of Science and Technology of China in Shenzhen, said there is a second pregnancy in his study.

Help 96

Help Study Research Technology 96

Xconomy

NOVEMBER 22, 2016

We are at an incredible inflection point in the traditionally distinct fields of information technology and the life sciences.

Technology 40

Technology Study Venture Capital Artificial Inteligence 40

socalTECH

MARCH 16, 2009

San Diego-based Cytori Therapeutics , which is developing medical technologies for regenerative medicine, said late Friday that the firm has raised $10M in a private placement. Source of the funding was not disclosed.

San Diego 100

San Diego Study Research Activity 100

Xconomy

AUGUST 17, 2016

Stengone said the new funding also will help the company evaluate the use of AVB-620 in other types of cancer surgery, to advance new cancer drugs that rely on Avelas’ proprietary technology, and to expand the company’s current roster of “seven employees and an army of consultants.”. Carmine Stengone.

Avalon 40

Avalon San Diego Study Invest 40

Xconomy

JUNE 12, 2019

Academic researchers have long studied gender and racial disparities in STEM education, but they have not had widespread success in addressing these challenges. A University of Michigan professor and colleagues from 10 universities are hoping to change that.

Equity 85

Equity Class Education Course 85

Xconomy

JANUARY 9, 2019

Beta Bionics, a startup developing a medical device that monitors and manages blood sugar levels in diabetes patients, has closed $63 million to back late-stage clinical tests of its AI-powered technology. The cash tops off a Series B round of funding announced last year.

Study 87

Study Design Capital Startup 87

Xconomy

SEPTEMBER 27, 2016

Fortis Therapeutics, a new San Diego biotech, has raised $18 million in initial funding to develop drugs for hard-to-treat prostate and bone marrow cancers. San Diego’s Avalon Ventures led the Series A round, and has established Fortis at COI Pharma, the firm’s biotech incubator (which now houses 16 life sciences startups).

Avalon 40

Avalon Funding Startup San Diego 40

Xconomy

OCTOBER 7, 2016

—Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology. CLINICAL NEWS.

Technical Review 77

Technical Review Study Layoffs San Diego 77

Xconomy

MAY 4, 2018

San Diego’s Histogen, a regenerative medicine company with technology for using nascent skin cells to produce “cosmeceutical” products, says the FDA has given a green light to its application for an initial safety study of its hair stimulation product in women.

Technical Review 73

Technical Review Study Product Technology 73

Xconomy

MAY 22, 2020

But Phase 1 clinical trials are small, and it’s unknown whether those early results can be replicated in larger studies. No major safety problems were reported and there were some indications that the injections elicited antibodies. Furthermore, Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

Study 80

Study Report San Diego Blogging 80

Xconomy

NOVEMBER 19, 2018

View the Slideshow On November 4-6, Xconomy organized a meeting of the minds—an elite gathering of leaders in technology, business, healthcare, education, and energy—to discuss and demonstrate the key trends in their fields, heading into next year. You can enjoy. Read more » Reprints | Share:

Artificial Inteligence 74

Artificial Inteligence Education Study Organization 74

Xconomy

MARCH 13, 2018

Of the various forms of the technology, CRISPR-Cas9 is the easiest to use, and it’s already showing up in summer camps and school science labs near you. A handful of drug companies have either begun or will soon begin human clinical studies of medicines that directly alter a patient’s genes. Gene editing has arrived.

Study 79

Study Activity Organization Technology 79

Xconomy

MAY 20, 2018

Today, we have biologic medicines, genomic sequencing technologies, and digital health tools that help patients become more engaged in their care. It’s during this process that investigational medicines are tested in controlled studies with patients. But one part of the equation hasn’t seen very much change at all: clinical trials.

Technical Review 66

Technical Review Study Tool Develop 66

socalTECH

OCTOBER 29, 2012

Those investors included a company called Paradigm, which is a big talent agency, Howard Lindzon in San Diego, and up north Greylock and Adam Nash. We set up to develop that technology, in partnership with institutions and researchers, psychologists, and marketing professors. It's not about us creating content, yet.

Content 230

Content News Startup Research 230

Xconomy

JULY 27, 2018

Eisai and partner Biogen released the highly anticipated details of an Alzheimer’s disease study they had already deemed positive, after an initial failure. In one sense, the study was the success they have claimed. The devil is in the details, and key clinical trial results made that abundantly clear this week.

Study 64

Study Invest San Diego Venture Capital 64

Xconomy

SEPTEMBER 9, 2016

It’s been almost two years since Organovo (NYSE: ONVO ) created a new business—using its bio-printing technology to create 3-D samples of living human liver tissue for use in testing the toxicity of pre-clinical drug candidates. It was a turning point because it wasn’t just us talking about our technology,” Murphy said. “It

Sample 40

Sample Screening Study San Diego 40